Hummus for Health: Dietary Quality and Health Outcomes in Toddlers

NCT02696278 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 139

Last updated 2017-07-17

No results posted yet for this study

Summary

The goal of this study is to examine the effect of increasing children's intake of fiber and unsaturated fat, through daily servings of hummus and vegetables, on their microbiome profile.

Conditions

Interventions

OTHER

Lesson about vegetables

During the introductory period, children will receive a lesson about vegetables 3 days a week for 3 weeks.

OTHER

Vegetables

During the introductory period, children will be served vegetables 3 days a week for 3 weeks during snack time at their daycare center. During the intervention period, children will receive vegetables everyday for 3 weeks during snack time at their daycare center.

OTHER

Hummus

During the introductory period, children will be served hummus, depending on their group assignment, 3 days a week for 3 weeks during snack time at their daycare center. During the intervention period, children will receive hummus, depending on their group assignment, everyday for 3 weeks during snack time at their daycare center.

Sponsors & Collaborators

  • Sabra Dipping Company, LLC

    collaborator OTHER
  • Baylor College of Medicine

    lead OTHER

Principal Investigators

  • Sheryl O Hughes, PhD · Baylor College of Medicine

  • Alexis Frazier-Wood, PhD · Baylor College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
12 Months
Max Age
24 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2016-12-31
Completion
2017-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02696278 on ClinicalTrials.gov